Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3698471013 | Conventional release suspension for endotracheopulmonary instillation (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3698472018 | Conventional release suspension for endotracheopulmonary instillation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 3698473011 | Suspension for endotracheopulmonary instillation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Conventional release suspension for endotracheopulmonary instillation (dose form) | Is a | Qualifier value | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Poractant alfa 80 mg/mL suspension for endotracheopulmonary instillation | Has manufactured dose form | True | Conventional release suspension for endotracheopulmonary instillation (dose form) | Inferred relationship | Some | |
| Product containing precisely phospholipid (as beractant) 25 milligram/1 milliliter conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has manufactured dose form | True | Conventional release suspension for endotracheopulmonary instillation (dose form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR